AUTHOR=Caldera-Crespo Luis A. , Paidas Michael J. , Roy Sabita , Schulman Carl I. , Kenyon Norma Sue , Daunert Sylvia , Jayakumar Arumugam R. 

TITLE=Experimental Models of COVID-19

JOURNAL=Frontiers in Cellular and Infection Microbiology

VOLUME=Volume 11 - 2021

YEAR=2022

URL=https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2021.792584

DOI=10.3389/fcimb.2021.792584

ISSN=2235-2988

ABSTRACT=COVID-19 is the most consequential pandemic of the 21st century. Since the earliest stage of the 2019-2020 epidemic, animal models have been useful in understanding the etiopathogenesis of SARS-CoV-2 infection and rapid development of vaccines/drugs to prevent, treat or eradicate SARS-CoV-2 infection. The scientific community determined the most useful models which could demonstrate viral infection, replication, transmission, and spectrum of illness as seen in human populations.  Until now, there have not been well-described animal models of SARS-CoV-2 infection although transgenic mouse models (i.e. mice with humanized ACE2 receptors with humanized receptors) have been proposed. Additionally, there are only limited facilities (Biosafety level 3 laboratories) available to contribute research to aid in eventually exterminating SARS-CoV-2 infection around the world. This review summarizes the most successful animal models of SARS-CoV-2 infection including studies in Non-Human Primates (NHPs) which were readily infected and transmitted the virus similarly to humans (e.g., Rhesus macaques, Cynomolgus, and African Green Monkeys), and animal models that do not require Biosafety level 3 laboratories (e.g., Mouse Hepatitis Virus models of COVID-19, Ferret model, Syrian Hamster model). The optimal model for research of SARS-CoV-2/COVID19 is the Murine Hepatitis Virus-1 Murine model. Exploring future animal models will aid researchers/scientists in discovering the mechanisms of SARS-CoV-2 infection and in identifying therapies to prevent or treat COVID-19.